TOPLINE In a cohort study of adults with type 2 diabetes, initiation of GLP-1 therapy was associated with a reduced 3- to 5-year risk of obesity-related cancers, but only relative to insulin or sulfonylureas. There was no significant difference in comparison with metformin or other diabetes medications…
Source

0 Comments

Leave a reply

©2026 Game Changers ®

Terms and Conditions | Disclaimer

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

Welcome

Install
×
PWA Add to Home Icon

Install this Game Changers on your iPhone PWA Add to Home Banner and then Add to Home Screen

×
x

Add Game Changers to your Homescreen by tap on share icon.

or

Log in with your credentials

or    

Forgot your details?

or

Create Account

Enable Notifications OK No thanks